September 12, 2019 Certara Launches Version 8.2 of its Industry-leading Phoenix PK/PD Modeling and Simulation Software for Drug Development
July 18, 2019 Certara Expands Evidence & Access Capabilities with Addition of Compass Consulting Team
June 25, 2019 Certara Announces First Recipients of Certara-Monash University Industry Drug Development Fellowships
June 12, 2019 Certara’s Simcyp PBPK Achieves First FDA Virtual Bioequivalence Approval for ‘Complex’ Generic Drug
June 11, 2019 Certara Scientists to Highlight Model-informed Drug Development, PBPK, MBMA and QSP Progress at PAGE 2019